Suchergebnisse - "Xu, Xu Steven"

PubPharm (5)

1

Clearance as an Early Indicator of Efficacy for Therapeutic Monoclonal Antibodies : Circumventing Dose Selection Challenges in Oncology

enthalten in: Clinical pharmacokinetics | 2023

von Chen, C. | Fan, X. | Zhang, L. | +7

2

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2017

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

3

Population pharmacokinetic analysis of abiraterone in chemotherapy-naïve and docetaxel-treated patients with metastatic castration-resistant prostate cancer

enthalten in: Clinical pharmacokinetics | 2014

von Stuyckens, K. | Saad, F. | Xu, X. | +7

4

Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency

enthalten in: The Journal of clinical endocrinology and metabolism | 2014

von Auchus, R. | Buschur, E. | Chang, A. | +9

5

Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain

enthalten in: Clinical pharmacokinetics | 2010

von Xu, X. | Smit, J. | Lin, R. | +3

1
[1]